MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Gamma Knife Radiosurgery for essential and parkinsonian tremor: Long-term experience in a Spanish center

    JR. Perez-Sanchez, R. Martinez-Alvarez, NE. Martinez-Moreno, I. Cuervo-Arango, G. Rey Portoles, I. Parees, A. Del Barrio, J. Alvarez-Linera, MM. Kurtis (Madrid, Spain)

    Objective: To describe the experience of a single Spanish center in gamma knife thalamotomy (GKT) as treatment of refractory tremor in patients with Essential Tremor…
  • 2018 International Congress

    Quantitative characterisation of tremor in functional and organic tremor patients

    Z. Dominguez-Vega, G. Kramer, J. Elting, M. de Koning-Tijssen, N. Maurits (Groningen, Netherlands)

    Objective: To quantify tremor characteristics using inertial sensors in functional and organic tremor patients and to present the differences in tremor quantification between these two…
  • 2018 International Congress

    Uric acid and cholesterol in patients with newly diagnosed essential tremor: Multicenter study

    S.Y. Kang, C. Lee, J.H. Yoon, J.H. Park, S.W. Choi, M.J. Son, J.Y. Hong, M.K. Sunwoo (Hwaseong, Republic of Korea)

    Objective: We hypothesized that uric acid (UA) level would be reduced and total cholesterol level would be increased if essential tremor (ET) is a neurodegenerative…
  • 2018 International Congress

    Eye Movements during Reading in Parkinson’s Disease: A Pilot Study

    J. Waldthaler, P. Tsitsi, G. Öqvist Seimyr, M. Nilsson Benfatto, P. Svenningsson (Marburg, Germany)

    Objective: To characterize eye movements during reading in patients with moderate stage Parkinson's disease (PD) with respect to medication state and cognitive ability. Background: Many…
  • 2018 International Congress

    Effective Tools for Mild Cognitive Impairment Level I Criteria of Movement Disorder Society: Utility of Screening Tests and Their Interconversion

    RL. Yu, WJ. Lee, JY. Li, YY. Chang, CC. Chen, JJ. Lin, YF. Sung, TK. Lin, RS. Chen, YH. Yang, YW. Yang, SJ. Wang, JL. Hsu, HC. Wang, JL. Fuh (Tainan, Taiwan)

    Objective: Our primary aim was to test the utility of the universally accepted screening tests for detecting mild cognitive impairment (MCI) in patients with Parkinson’s…
  • 2018 International Congress

    The relationship between asymmetric dopamine loss and cognition in early Parkinson’s disease patients from PPMI study

    R. Biundo, E. Fiorenzato, L. Weis, A. Antonini (Venice, Italy)

    Objective: To explore the role of motor asymmetry on cognition in early stage Parkinson’s disease (PD). Background: PD is characterized by asymmetric motor onset which…
  • 2018 International Congress

    Agreement Between Patients and Informants on the Penn Parkinson’s Daily Activity Questionnaire

    B. Deck, S. Xie, J. Rick, A. Chen-Plotkin, J. Duda, J. Morley, N. Dahodwala, J. Trojanowski, D. Weintraub (Philadelphia, PA, USA)

    Objective: To assess agreement between Parkinson’s disease (PD) patients (PT) and knowledgeable informants (KI) on the Penn Parkinson’s Daily Activities Questionnaire-15 (PDAQ-15). To explore conditions…
  • 2018 International Congress

    Effect of deep brain stimulation on clinical outcome in Parkinson’s disease patients with different genetic status

    M. Kestenbaum, R. Schvartz, Y. Balash, A. Hilel, A. Mirelman, N. Giladi, T. Gurevich (Tel Aviv, Israel)

    Objective: The aim of this study was to evaluate the effect of the genetic status on the clinical outcome of PD patients undergoing DBS. Background:…
  • 2018 International Congress

    Resistance to Parkinson’s disease among LRRK2 mutation carriers is associated with higher plasma levels of urate but not its purine precursors

    M. Schwarzschild, R. Bakshi, R. Logan, M. Zorlu, X. Chen, A. Ascherio, E. Macklin (Boston, MA, USA)

    Objective: To determine whether plasma purine concentrations differ between people with Parkinson's disease (PD) and matched controls among carriers of pathogenic mutations in Leucine-Rich Repeat…
  • 2018 International Congress

    Nurr1 gene: A new research target for Parkinson’s disease

    W. Le (Dalian, China)

    Objective: The objective of our study is to determine if Nurr1 gene, a transcription factor essential for dopamine (DA) neuron development and survival, is a…
  • « Previous Page
  • 1
  • …
  • 39
  • 40
  • 41
  • 42
  • 43
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
        • Help & Support
        • About Us
        • Cookies & Privacy
        • Wiley Job Network
        • Terms & Conditions
        • Advertisers & Agents
        Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
        Wiley